A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML.
作者信息
Kats L M, Vervoort S J, Cole R, Rogers A J, Gregory G P, Vidacs E, Li J, Nagaraja R, Yen K E, Johnstone R W
机构信息
Cancer Therapeutics Program, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
The Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia.
出版信息
Leukemia. 2017 Jun;31(6):1466-1470. doi: 10.1038/leu.2017.84. Epub 2017 Mar 10.
PMID:28280273
Abstract
摘要
Zotero 插件